Alzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.
Alzheimer’s disease
Porphyromonas gingivalis
gingipain cysteine endopeptidases
in vitro techniques
multivesicular bodies
synapses
tau protein
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
12
5
2020
medline:
14
5
2021
entrez:
12
5
2020
Statut:
ppublish
Résumé
Porphyromonas gingivalis (P. gingivalis) and its gingipain virulence factors have been identified as pathogenic effectors in Alzheimer's disease (AD). In a recent study we demonstrated the presence of gingipains in over 90% of postmortem AD brains, with gingipains localizing to the cytoplasm of neurons. However, infection of neurons by P. gingivalis has not been previously reported. To demonstrate intraneuronal P. gingivalis and gingipain expression in vitro after infecting neurons derived from human inducible pluripotent stem cells (iPSC) with P. gingivalis for 24, 48, and 72 h. Infection was characterized by transmission electron microscopy, confocal microscopy, and bacterial colony forming unit assays. Gingipain expression was monitored by immunofluorescence and RT-qPCR, and protease activity monitored with activity-based probes. Neurodegenerative endpoints were assessed by immunofluorescence, western blot, and ELISA. Neurons survived the initial infection and showed time dependent, infection induced cell death. P. gingivalis was found free in the cytoplasm or in lysosomes. Infected neurons displayed an accumulation of autophagic vacuoles and multivesicular bodies. Tau protein was strongly degraded, and phosphorylation increased at T231. Over time, the density of presynaptic boutons was decreased. P. gingivalis can invade and persist in mature neurons. Infected neurons display signs of AD-like neuropathology including the accumulation of autophagic vacuoles and multivesicular bodies, cytoskeleton disruption, an increase in phospho-tau/tau ratio, and synapse loss. Infection of iPSC-derived mature neurons by P. gingivalis provides a novel model system to study the cellular mechanisms leading to AD and to investigate the potential of new therapeutic approaches.
Sections du résumé
BACKGROUND
Porphyromonas gingivalis (P. gingivalis) and its gingipain virulence factors have been identified as pathogenic effectors in Alzheimer's disease (AD). In a recent study we demonstrated the presence of gingipains in over 90% of postmortem AD brains, with gingipains localizing to the cytoplasm of neurons. However, infection of neurons by P. gingivalis has not been previously reported.
OBJECTIVE
To demonstrate intraneuronal P. gingivalis and gingipain expression in vitro after infecting neurons derived from human inducible pluripotent stem cells (iPSC) with P. gingivalis for 24, 48, and 72 h.
METHODS
Infection was characterized by transmission electron microscopy, confocal microscopy, and bacterial colony forming unit assays. Gingipain expression was monitored by immunofluorescence and RT-qPCR, and protease activity monitored with activity-based probes. Neurodegenerative endpoints were assessed by immunofluorescence, western blot, and ELISA.
RESULTS
Neurons survived the initial infection and showed time dependent, infection induced cell death. P. gingivalis was found free in the cytoplasm or in lysosomes. Infected neurons displayed an accumulation of autophagic vacuoles and multivesicular bodies. Tau protein was strongly degraded, and phosphorylation increased at T231. Over time, the density of presynaptic boutons was decreased.
CONCLUSION
P. gingivalis can invade and persist in mature neurons. Infected neurons display signs of AD-like neuropathology including the accumulation of autophagic vacuoles and multivesicular bodies, cytoskeleton disruption, an increase in phospho-tau/tau ratio, and synapse loss. Infection of iPSC-derived mature neurons by P. gingivalis provides a novel model system to study the cellular mechanisms leading to AD and to investigate the potential of new therapeutic approaches.
Identifiants
pubmed: 32390638
pii: JAD200393
doi: 10.3233/JAD-200393
pmc: PMC7369049
doi:
Substances chimiques
Gingipain Cysteine Endopeptidases
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1361-1376Références
Alzheimers Dement. 2006 Apr;2(2):110-7
pubmed: 19595867
Prog Neurobiol. 2011 Mar;93(3):313-40
pubmed: 21216273
J Neurosci. 2008 Jul 2;28(27):6926-37
pubmed: 18596167
J Neuropathol Exp Neurol. 2005 Feb;64(2):113-22
pubmed: 15751225
J Neurosci. 2013 Sep 25;33(39):15362-75
pubmed: 24068803
Arch Oral Biol. 2017 Nov;83:265-271
pubmed: 28841474
J Alzheimers Dis. 2015;43(1):67-80
pubmed: 25061055
J Alzheimers Dis. 2015;43(3):1073-90
pubmed: 25147118
J Dent Res. 2012 Sep;91(9):816-20
pubmed: 22772362
PLoS One. 2018 Oct 3;13(10):e0204941
pubmed: 30281647
Infect Immun. 2004 Oct;72(10):5910-8
pubmed: 15385493
Appl Environ Microbiol. 2000 Oct;66(10):4564-7
pubmed: 11010918
J Periodontal Res. 1999 Oct;34(7):393-9
pubmed: 10685367
Curr Biol. 2018 Jul 9;28(13):2181-2189.e4
pubmed: 30008334
PLoS One. 2016 Feb 19;11(2):e0149618
pubmed: 26894834
Am J Blood Res. 2019 Feb 15;9(1):1-14
pubmed: 30899601
Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2725-34
pubmed: 25870293
Infect Immun. 1995 Oct;63(10):3878-85
pubmed: 7558295
Comput Struct Biotechnol J. 2014 Oct 02;12(20-21):7-13
pubmed: 25505502
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7501-6
pubmed: 26034266
PLoS Pathog. 2015 Feb 13;10(2):e1004647
pubmed: 25679217
PLoS One. 2012;7(12):e52606
pubmed: 23300720
Oral Microbiol Immunol. 2004 Apr;19(2):88-94
pubmed: 14871347
Eur J Oral Sci. 2018 Oct;126(5):367-372
pubmed: 30070725
J Biol Chem. 2013 Aug 9;288(32):23331-47
pubmed: 23798682
J Biol Chem. 2012 Jun 8;287(24):20613-24
pubmed: 22544751
Cell Microbiol. 1999 Nov;1(3):215-23
pubmed: 11207554
Sci Adv. 2019 Jan 23;5(1):eaau3333
pubmed: 30746447
BMC Microbiol. 2014 Oct 02;14:258
pubmed: 25270662
J Cell Sci. 2013 Jun 1;126(Pt 11):2319-29
pubmed: 23729742
BMC Microbiol. 2008 Feb 06;8:26
pubmed: 18254977
Front Microbiol. 2014 Jun 02;5:258
pubmed: 24917854
PLoS One. 2016 Mar 10;11(3):e0151081
pubmed: 26963387
J Cell Sci. 2007 Dec 1;120(Pt 23):4081-91
pubmed: 18032783
J Intern Med. 2011 Sep;270(3):273-80
pubmed: 21366733
Neuropathol Appl Neurobiol. 2014 Feb;40(2):121-35
pubmed: 24033439
J Neurosci Res. 2012 Feb;90(2):422-34
pubmed: 22002503
Curr Protein Pept Sci. 2003 Dec;4(6):443-50
pubmed: 14683429
Infect Immun. 2007 May;75(5):2090-100
pubmed: 17296756
Curr Biol. 2012 Jul 10;22(13):R540-5
pubmed: 22790007
J Biol Chem. 1992 Jan 25;267(3):1563-8
pubmed: 1730702
J Oral Microbiol. 2014 Aug 18;6:
pubmed: 25206939
J Am Geriatr Soc. 2010 Apr;58(4):713-8
pubmed: 20398152
Structure. 2015 Aug 4;23(8):1448-1458
pubmed: 26165593
J Alzheimers Dis. 2013;33 Suppl 1:S123-39
pubmed: 22710920
J Microbiol Methods. 2011 Aug;86(2):266-73
pubmed: 21616099
J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1206-11
pubmed: 19419981
Neurobiol Aging. 2015 Feb;36(2):627-33
pubmed: 25491073
Front Aging Neurosci. 2019 Aug 07;11:204
pubmed: 31447664
Biomolecules. 2016 Jan 06;6(1):6
pubmed: 26751493
Infect Immun. 2001 Sep;69(9):5698-708
pubmed: 11500446
Eur J Immunol. 2014 Feb;44(2):328-38
pubmed: 24338806
J Am Dent Assoc. 2007 Oct;138(10):1314-22; quiz 1381-2
pubmed: 17908844